Trends & Forecasts

Could non-pathogenic viruses provide an unrejectable therapeutic target?

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

How Tosoh Biosciences is contributing to a fascinating project on a mission to develop a continuous production process using Escherichia Coli

US-based law and patenting experts offer their thoughts on IP protection in the digital age

Experts discuss the most promising growth prospects in the cell and gene landscape

We need non-opioid options for pain relief. Paradigm Biopharmaceuticals discuss their studies into a new option for osteoarthritis patients

What sustainability benefits can be gained from smart choices and reduced material use?

Transporting temperature-sensitive pharmaceuticals is only going to become more challenging as we face the realities of the climate crisis.